Aeglea Biotherapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $67M | 4.0M | 16.76 |
| 2025-06-30 | $60M | 4.0M | 14.97 |
| 2025-03-31 | $58M | 3.6M | 16.14 |
| 2024-12-31 | $79M | 3.4M | 23.28 |
| 2024-09-30 | $78M | 2.7M | 29.41 |